By Steve Moore | Thursday 18 December 2014
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Robotic technology that enhances the mobility of wheel-chair users-focused, Rex Bionics (RXB) has updated that “sales are currently materially behind market expectations” and “in the period ending 31 March 2015 will be only a nominal amount”. However, with the company now set on generating “as rapidly as possible the clinical data required to support the clinical and quality-of-life benefits that we believe REX can deliver”, is a near halving of the share price currently today, to circa 70p, overdone?
Filed under:
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Time left: 07:14:24